Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	36.94B +0.1%
Revenue (ttm)	7.46B +17.1%
Net Income	1.69B +28.7%
EPS	15.06 +28.6%
Shares Out	111.98M
PE Ratio	21.90
Forward PE	21.28
Dividend	5.35 (1.62%)
Ex-Dividend Date	Jul 24, 2026

Volume	149,899
Open	330.30
Previous Close	324.35
Day's Range	325.30 - 333.00
52-Week Range	251.95 - 419.00
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 409
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In fiscal year 2026, NSE:ADVENZYMES's revenue was 7.46 billion, an increase of 17.09% compared to the previous year's 6.37 billion. Earnings were 1.69 billion, an increase of 28.68%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error